AVITA Medical Inc.

AI Score

0

Unlock

10.03
-0.19 (-1.86%)
At close: Feb 20, 2025, 3:59 PM
9.96
-0.70%
After-hours: Feb 20, 2025, 07:05 PM EST
undefined%
Bid 9.8
Market Cap 264.37M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.39
PE Ratio (ttm) -4.2
Forward PE n/a
Analyst Buy
Ask 9.99
Volume 218,951
Avg. Volume (20D) 180,745
Open 10.31
Previous Close 10.22
Day's Range 9.80 - 10.31
52-Week Range 7.51 - 18.93
Beta undefined

About RCEL

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a ...

Sector Healthcare
IPO Date May 14, 2012
Employees 260
Stock Exchange NASDAQ
Ticker Symbol RCEL
Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for RCEL stock is "Buy." The 12-month stock price forecast is $17.5, which is an increase of 74.48% from the latest price.

Buy 60.00%
Hold 40.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

AVITA Medical Inc. is scheduled to release its earnings on May 12, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago
+20.39%
AVITA Medical shares are trading higher. The compa... Unlock content with Pro Subscription
1 month ago
-36.42%
Avita Medical shares are trading lower after Lake Street cut its price target on the stock from $20 to $14.